Psychosis in late life: Emerging issues

Journal of Psychosocial Nursing and Mental Health Services

Volumn 46, Issue 11, 2008, Pages 45-52

  Reeves, Roy R ^a,b   Brister, James C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56349151876     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20081101-09     Document Type: Review

References (39)

1. rd ed.). Washington, DC: Author.
2. rd ed., Rev.). Washington, DC: Author.
3. th ed.). Washington, DC: Author.
4. th ed., Text Rev.). Washington, DC: Author.
5. Bleuler, M. (1943). Die spatschizophrenen. Krankheitbilder, Fortschritte der Neurologie und Psychiatrie Grenzgeb, 15, 259-290.
6. Castle, D.J., & Murray, R.M. (1993). The epidemiology of late-onset schizophrenia. Schizophrenia Bulletin, 19, 691-700.
7. Cervantes, A.N., Rabins, P.V., & Slavney, P.R. (2006). Onset of schizophrenia at age 100. Psychosomatics, 47, 356-359.
8. Davidson, M., Harvey, P.D., Powchik, P., Parrella, M., White, L., Knobler, H.Y., et al. (1995). Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. American Journal of Psychiatry, 152, 197-207.
9. Evans, J.D., Paulsen, J.S., Harris, M.J., Heaton, R.K., & Jeste, D.V. (1996). A clinical and neuropsychological comparison of delusional disorder and schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 8, 281-286.
10. Granholm, E., McQuaid, J.R., McClure, F.S., Pedrelli, P., & Jeste, D.V. (2002). A randomized controlled pilot study of cognitive behavioral social skills training for older individuals with schizophrenia [Letter]. Schizophrenia Research, 153, 167-169.
11. Harris, M.J., & Jeste, D.V. (1988). Late-onset schizophrenia: An overview. Schizophrenia Bulletin, 14, 39-55.
12. Heaton, R.K., Gladsjo, J.A., Palmer, B.W., Kuck, J., Marcotte, T.D., & Jeste, D.V. (2001). Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry, 58, 24-32.
13. Hirose, T., Uwahodo, Y., Yamada, S., Miwa, T., Kikuchi, T., Kitagawa, H., et al. (2004). Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. Journal of Psychopharmacology, 18, 375-383.
14. Howard, R., Castle, D., Wessely, S., & Murray, R. (1993). A comparative study of 470 cases of early-onset and late-onset schizophrenia. British Journal of Psychiatry, 163, 352-357.
15. Howard, R., Rabbins, P.V., Seeman, M.V., & Jeste, D.V. (2000). Late-onset schizophrenia and very-late onset schizophrenia-like psychosis: An international consensus. The International Late-Onset Schizophrenia Group. American Journal of Psychiatry, 157, 172-178.
16. Huber, G. (1997). The heterogeneous course of schizophrenia. Schizophrenia Research, 28, 177-185.
17. Jeste, D.V., & Finkel, S.I. (2000). Psychosis of Alzheimer's disease and related dementias: Diagnostic criteria for a distinct syndrome. American Journal of Geriatric Psychiatry, 8, 29-34.
18. Jeste, D.V., Harris, M.J., Krull, A., Kuck, J., McAdams, L.A., & Heaton, R. (1995). Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. American Journal of Psychiatry, 152, 722-730.
19. rd ed., pp. 269-282). Washington, DC: American Psychiatric Publishing.
20. Katz, I.R., Jeste, D.V., Mintzer, J.E., Clyde, C., Napolitano, J., & Brecher, M. (1999). Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Journal of Clinical Psychiatry, 60, 107-115.
21. Keith, S.J., Regier, D.A., & Rae, D.S. (1991). Schizophrenic disorders. In L.N. Robins & D.A. Regier (Eds.), Psychiatric disorders in America: The Epidemiological Catchment Area Study (pp. 33-52). New York: The Free Press.
22. Kraepelin, E. (1919). Dementia praecox and paraphrenia (R.M. Barclay, Trans.). Huntington, NY: Krieger.
23. Lindboe, C.F., & Hansen, H.B. (1998). The frequency of Lewy bodies in a consecutive autopsy series. Clinical Neuropathology, 17, 204-209.
24. Madhusoodanan, S., Suresh, P., Brenner, R., & Pillai, R. (1999). Experience with the atypical antipsychotics - Risperidone and olanzapine in the elderly. Annals of Clinical Psychiatry, 11, 113-118.
25. Naimark, D., Jackson, E., Rockwell, E., & Jeste, D.V. (1996). Psychotic symptoms in Parkinson's disease patients with dementia. Journal of the American Geriatrics Society, 44, 296-299.
26. Ostling, S., & Skoog, I. (2002). Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Archives of General Psychiatry, 59, 53-59.
27. Palmer, B.W., Bondi, M.W., Twamley, E.W., Thal, L., Golshan, S., & Jeste, D.V. (2003). Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 45-52.
28. Prager, S., & Jeste, D.V. (1993). Sensory impairment in late-life schizophrenia. Schizophrenia Bulletin, 19, 755-772.
29. Reeves, R.R., & Struve, F.A. (2003). Quantitative electroencephalography in late-onset schizophrenia. International Psychogeriatrics, 15, 273-278.
30. Rockwell, E., Jackson, E., Vilke, G., & Jeste, D.V. (1994). A study of delusions in a large cohort of Alzheimer's disease patients. American Journal of Geriatric Psychiatry, 2, 157-164.
31. Stern, Y., Albert, M., Brandt, J., Jacobs, D.M., Tang, M.X., Marder, K., et al. (1994). Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: Prospective analyses from the Predictors Study. Neurology, 44, 2300-2307.
32. Symonds, L.L., Olichney, J.M., Jernigan, T.L., Corey-Bloom, J., Healy, J.F., & Jeste, D.V. (1997). Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 251-258.
33. Tonkonogy, J.M., & Geller, J.L. (1999). Late-onset paranoid psychosis as a distinct clinicopathological entity: Magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 12, 230-235.
34. Tune, L.E., & Salzman, C. (2003). Schizophrenia in late life. Psychiatric Clinics of North America, 26, 103-113.
35. U.S. Food and Drug Administration. (2008). Information for healthcare professionals: Antipsychotics. Retrieved August 25, 2008, from http://www.fda.gov/CDER/drug/InfoSheets/HCP/antipsychotics_conventional.htm
36. Webster, J., & Grossberg, G.T. (1998). Late-life onset of psychotic symptoms. The American Journal of Geriatric Psychiatry, 6, 196-202.
37. Wynn, Z.J., & Cummings, J.L. (2004). Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 17(1-2), 100-108.
38. Wynn Owen, P.A., & Castle, D.J. (1999). Late-onset schizophrenia: Epidemiology, diagnosis, management, and outcomes. Drugs & Aging, 15, 81-89.
39. nd ed., pp. 511-525). Chichester, United Kingdom: Wiley & Sons.